<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Monosomal karyotype (MK) has recently been associated with poor prognosis in <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>), <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), and primary <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> (PMF) </plain></SENT>
<SENT sid="1" pm="."><plain>The objectives of the current study were to describe the prevalence and spectrum of autosomal <z:mp ids='MP_0004026'>monosomies</z:mp> in an unselected cohort of patients with known or suspected <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Bone marrow cytogenetic studies (24,262) were performed at our institution between 1989 and 2009 </plain></SENT>
<SENT sid="3" pm="."><plain>An abnormal karyotype was demonstrated in 6,565 cases (~27%); of these, 1,365 (~21%) included autosomal <z:mp ids='MP_0004026'>monosomies</z:mp> that occurred as sole (n = 133; ~10%), part of two (n = 82; ~6%) or more (n = 1,150; ~84%) anomalies </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> 22 autosomes were involved, but <z:mp ids='MP_0004026'>monosomy</z:mp> 7 was by far the most frequent, constituting ~80% of <z:hpo ids='HP_0000001'>all</z:hpo> isolated <z:mp ids='MP_0004026'>monosomies</z:mp> and the highest fraction of those with two or more abnormalities </plain></SENT>
<SENT sid="5" pm="."><plain>Other recurrent sole <z:mp ids='MP_0004026'>monosomies</z:mp> included chromosomes 20 (~11%) and 21 (~4%) </plain></SENT>
<SENT sid="6" pm="."><plain><z:mp ids='MP_0004026'>Monosomy</z:mp> 13 (~10%), 20 (~8%), 18 (~7%), 17 (~6%), 21 (~5%), 5 (~5%), and 12 (~4%) were also recurrent in the setting of â‰¥2 abnormalities </plain></SENT>
<SENT sid="7" pm="."><plain>Bone marrow histology and clinical information were reviewed in <z:hpo ids='HP_0000001'>all</z:hpo> cases with isolated <z:mp ids='MP_0004026'>monosomy</z:mp>; associated clinical phenotypes were <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (n = 60; 52 were -7), <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> (n = 32; 31 were -7), myeloproliferative <z:hpo ids='HP_0002664'>neoplasms</z:hpo> (n = 16; 10 were -7), <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e>; n = 10; 9 were -7) and other nonmyeloid <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> (n = 15; 4 were -7) </plain></SENT>
<SENT sid="8" pm="."><plain>Sole <z:mp ids='MP_0004026'>monosomy</z:mp> 20 (n = 14; six <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, five MPN, and three nonmyeloid) was not seen in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Sole <z:mp ids='MP_0004026'>monosomy</z:mp> 21 was more frequent in nonmyeloid as opposed to myeloid cases </plain></SENT>
</text></document>